BioSpace News Archive

ResMed (NYSE: RMD, ASX: RMD) today announced it plans to release financial and operational results for the third quarter of fiscal year 2019 on Thursday, May 2, 2019, after the New York Stock Exchange closes.

PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, today announced that on Thursday, April 25, 2019, after market close, the Company will release first quarter 2019 results.

AcelRx Pharmaceuticals, Inc. announced an abstract about the safety of DSUVIA™ has been selected, as one of the highest scoring abstracts, for a moderated presentation at the 44th Annual Regional Anesthesiology & Acute Pain Medicine Meeting taking place from April 11-13 in Las Vegas, Nevada.

With a Performance by Multi-Platinum Pop Artist Andy Grammer and a Prelude Performance by The Ransom Notes at the Annual AcceptAbility Gala in DC

Data presented in Late-Breaking Presentation at the EASL International Liver Congress™ [11-April-2019] SAN FRANCISCO and HERZLIYA, Israel , April 11, 2019 /PRNewswire/ -- 89bio LTD, a clinical-stage biopharmaceutical company focused on nonalcoholic steatohepatitis (NASH) and other liver and metabolic disorders, today announced that preclinical data of its investigat

Protagen Protein Services GmbH (PPS), a full-service contract research organization (CRO) in protein analytics and BioAnalytix Inc., a Cambridge (MA)-based specialized provider of advanced analytics in biopharmaceutical development announced today a merger that will transform the combined company into a leading global analytic services provider for the biopharmaceutical industry.

KingFisher Ready DNA Ultra 2.0 prefilled plates are ready-to-use reagents designed exclusively for KingFisher instruments.

VirtualMED is partnering with HealthTap, a US-based health technology company, to provide Canadians with easy access to high quality, AI-powered virtual care.

Dr. Eric A. Levine joins mental health healing community April 15

Jennifer Schneider, PhD. Vice President, Business Development at Centauri Therapeutics, will be presenting during the “Therapeutics pipeline corner” session, at 12.15pm CET on 14 April 2019.